Tenaya Therapeutics Inc (TNYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 23,872 | N/A | N/A |
| Marketable Securities | 2,753 | N/A | N/A |
| TOTAL | $27,742 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 9,575 | N/A | N/A |
| Other Non-Current Assets | 684 | 0 | 0 |
| TOTAL | $10,259 | $N/A | $N/A |
| Total Assets | $38,001 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 600 | 0 | 0 |
| Accrued Expenses | 1,959 | N/A | N/A |
| Other current liabilities | 786 | N/A | N/A |
| TOTAL | $4,120 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Deferred Revenues | 775 | N/A | N/A |
| Other Non-Current Liabilities | 53 | 0 | 0 |
| TOTAL | $4,578 | $N/A | $N/A |
| Total Liabilities | $8,698 | $N/A | $N/A |
| Shareholders' Equity | |||
| Retained earnings | -44,417 | N/A | N/A |
| Other shareholders' equity | -86 | 0 | 0 |
| TOTAL | $29,303 | $N/A | $N/A |
| Total Liabilities And Equity | $38,001 | $0 | $0 |